In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Zoetis Inc (NYSE: ZTS) closed the day trading at $119.56 down -0.77% from the previous closing price of $120.49. In other words, the price has decreased by -$0.77 from its previous closing price. On the day, 6.99 million shares were traded. ZTS stock price reached its highest trading level at $121.5 during the session, while it also had its lowest trading level at $119.06.
Ratios:
For a better understanding of ZTS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 25.28 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.52. For the most recent quarter (mrq), Quick Ratio is recorded 2.28 and its Current Ratio is at 3.64. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.35.
On June 18, 2025, Stifel Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $160.
On December 02, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $215.Leerink Partners initiated its Outperform rating on December 02, 2024, with a $215 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’25 when Lagano Roxanne sold 652 shares for $170.00 per share. The transaction valued at 110,840 led to the insider holds 15,129 shares of the business.
Lagano Roxanne bought 652 shares of ZTS for $110,840 on Jun 03 ’25. On Mar 11 ’25, another insider, Reed Willie M, who serves as the Director of the company, bought 1,210 shares for $166.14 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 52689281024 and an Enterprise Value of 57895280640. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.15, and their Forward P/E ratio for the next fiscal year is 17.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.61 while its Price-to-Book (P/B) ratio in mrq is 9.78. Its current Enterprise Value per Revenue stands at 6.161 whereas that against EBITDA is 14.602.
Stock Price History:
The Beta on a monthly basis for ZTS is 0.98, which has changed by -0.31857258 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, ZTS has reached a high of $181.85, while it has fallen to a 52-week low of $119.07. The 50-Day Moving Average of the stock is -17.49%, while the 200-Day Moving Average is calculated to be -23.28%.
Shares Statistics:
Over the past 3-months, ZTS traded about 3.04M shares per day on average, while over the past 10 days, ZTS traded about 4146480 shares per day. A total of 443.18M shares are outstanding, with a floating share count of 442.39M. Insiders hold about 0.18% of the company’s shares, while institutions hold 96.96% stake in the company. Shares short for ZTS as of 1760486400 were 8734430 with a Short Ratio of 2.87, compared to 1757894400 on 9188089. Therefore, it implies a Short% of Shares Outstanding of 8734430 and a Short% of Float of 1.97.
Dividends & Splits
ZTS’s forward annual dividend rate is 2.00, up from 1.932 a year ago. Against a Trailing Annual Dividend Yield of 0.016034527. The stock’s 5-year Average Dividend Yield is 0.81.
Earnings Estimates
The firm’s stock currently is rated by 13.0 analysts. The consensus estimate for the next quarter is $1.57, with high estimates of $1.63 and low estimates of $1.54.
Analysts are recommending an EPS of between $6.4 and $6.3 for the fiscal current year, implying an average EPS of $6.34. EPS for the following year is $6.82, with 18.0 analysts recommending between $7.09 and $6.43.
Revenue Estimates
10 analysts predict $2.37B in revenue for. The current quarter. It ranges from a high estimate of $2.46B to a low estimate of $2.34B. As of. The current estimate, Zoetis Inc’s year-ago sales were $2.32BFor the next quarter, 10 analysts are estimating revenue of $2.34B. There is a high estimate of $2.38B for the next quarter, whereas the lowest estimate is $2.31B.
A total of 16 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $9.55B, while the lowest revenue estimate was $9.42B, resulting in an average revenue estimate of $9.47B. In the same quarter a year ago, actual revenue was $9.26BBased on 16 analysts’ estimates, the company’s revenue will be $9.97B in the next fiscal year. The high estimate is $10.22B and the low estimate is $9.74B.
